699810P

PHAD^™-504

Avanti Research^™ - A Croda Brand

• Synonym(e): Monophosphoryl Lipid A-504
• Empirische Formel (Hill-System): C₉₄H₁₈₀ N₃O₂₂P
• CAS-Nummer: 1332714-01-8
• Molekulargewicht: 1735.42
• UNSPSC-Code: 12352211
• NACRES: NA.25

Eigenschaften

• Assay: >99% (HPLC)
• Form: powder
• Verpackung: pkg of 1 × 1 mg (699810P-1mg); pkg of 1 × 5 mg (699810P-5mg)
• Hersteller/Markenname: Avanti Research^™ - A Croda Brand
• Anwendung(en): vaccine development
• Versandbedingung: dry ice
• Lagertemp.: −20°C

Beschreibung

Allgemeine Beschreibung

PHAD^™-504 was designed as a synthetic structural analog of detoxified monophosphoryl lipid A (MPLA) derived from E. coli lipopolysaccharide (LPS). It is structurally similar to PHAD^™, differing only in the length of a single fatty acid chain. As expected, the activity of PHAD^™-504 is quite similar to that of PHAD^™, making the two products interchangeable as adjuvants in vaccine or immunotherapy formulations.

Verpackung

2 mL Amber Glass Crimp Cap Vial (699810P-1mg)

2 mL Amber Glass Crimp Cap Vial (699810P-5mg)

Sonstige Hinweise

For R&D use only. Not for drug, household, or other uses.

Rechtliche Hinweise

Avanti Research is a trademark of Avanti Polar Lipids, LLC

PHAD is a trademark of Avanti Polar Lipids, LLC

Sicherheitshinweise

• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 3
• Flammpunkt (°F): No data available
• Flammpunkt (°C): No data available